GLHs June Quarterly Business Activity Report and Appendix 4C

Global Health Limited (ASX: GLH) issued its Quarterly Business Activity Report and Appendix 4C Cash Flow Report for Q4 FY23, ending on 30 June 2023. During this period, the company's Australian operations experienced a positive cash flow, with strong customer revenues and operating profits (pre-R&D expense) doubling.

The total cash flow deficit for the group in the June Quarter was (AU$390K), which was notably 64% lower than the deficit of (AU$3,045K) reported in the first half of the financial year ending in December 2022 (H1 FY23). Furthermore, the Australian operations showed significant performance improvement compared to the previous financial year ended on 30 June 2022, with customer revenue increasing by 20% to AU$7.8 million, professional services up by over 100% to AU$1.4 million, annual recurring revenue up by 12% to AU$5.7 million.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com